This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
for women) in states that legalized medical cannabis programs, and a possible relationship between cannabis use and atrial fibrillation, while also noting that data and statistical adjustment from this and similar studies may have failed to take into account concomitant use of tobacco or other drugs. for men, 1.3%
It has also recently began flexing extra-territoriality muscles in regards to data regulation, positioning itself as a world police of consumer data, to the chagrin of Silicon Valley’s luminaries. It has long kicked back against trends emerging from the US in financial and other markets, not least since the 2008 financial crisis.
For the study, reported on by Reuters, researchers examined data collected from a total of almost 729,000 people aged 12 years and older between 2005 and 2017, including any prior-month cannabis use and any depression experienced over the previous year. “In 2005, about 10.2% “In 2005, about 10.2%
Regarding the warning for specific populations that based on animal data the pharmaceutical may cause fetal harm. There is sufficient data, as indicated in discussion, that inert ingredients within this newly approved CBD pharmaceutical for the US Market have already been proven to cause harm in the unborn fetus, and not the cannabinoid.
Ratsch, 2005) “The gelotophllis of Pliny… a plant drunk in wine among the Bactrians, which produced immoderate laughter, may very well be identical with hemp, which still grows willd in the country around the Caspian and Aral Seas” (Houtsma, et al., The Hard data of hallucinogenic beer at Mas Castellar de Pontos says otherwise.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content